About
Christine Günther, MD, PhD is a biotech executive and advisor focused on advanced therapies, especially cell and gene therapy. Bloomberg Live identified her as CEO of Apceth Biopharma in 2020, and Viopas Venture Consulting announced in December 2025 that she joined the firm as a Partner. Fraunhofer IBMT also lists her on its advisory board, reflecting an industry-influence and scientific translation profile rather than a capital deployment profile.
Areas of interest
biotechcell therapygene therapyadvanced therapiesregenerative medicineclinical translationATMP manufacturingoncologyhealthcare venture advisory